Monograph: Addressing Clinical Inertia and Patient Needs with Complementary Insulin-Based Therapies
Efforts to reduce PA clinical inertia and increase patient acceptance of combination injectable therapy when basal insulin is no longer sufficient to maintain euglycemia is paramount to improving outcomes for patients with Type 2 Diabetes Mellitus (T2DM). This activity outlines effective treatment practices for patients with T2DM.
Educational ObjectivesAt the conclusion of this activity, the PA should be better able to:
- Implement the most effective treatment practices for patients with T2DM that can achieve quality measures to improve patient outcomes and reduce the incidence of adverse healthcare-associated conditions and costs while meeting patient needs.
- Identify treatment options that can achieve the trifecta of glycemic control, with low risks of hypoglycemia, avoidance of weight gain, and work with patients to minimize clinical inertia.
- State why early combination therapy for patients with substantial elevation of A1C levels, or A1C levels not at goal despite normal fasting plasma glucose at goal, is appropriate and safe for T2DM patients.
- Integrate shared decision making into practice and involve patients in the decision-making process regarding treatment goals, treatment options, and flexibility.